Journal of Pharmacy Technology: Official Publication of the Association of Pharmacy Technicians January-December 2005: Vol 21 Index

2 MB·English

INDEX, the journal of Pharmacy Technology
VOLUME Twenty-one — JANUARY THROUGH DECEMBER 2005
January/February Pages 1-56 July/August Pages 189-244
March/April Pages 57-120 September/October Pages 245-316
May/June Pages 121-188 November/December Pages 317-382
methicillin-resistant Staphylococcus aureus Congestive Heart Failure: Does Multiple-
A-C (A), 123; growing problem of Escherichia Daily Dosing Provide Additional Benefit
coli-caused urinary tract infections (WN), Over Once-Daily Dosing? (A), 203
A Case Study: Treatment of Refractory 100; resistance reversed by new vaccine B-blockers, reduce complications after cardiac
Schizoaffective Disorder with Aripipra- (WN), 162 surgery (TT), 28
zole (A), 150 Antibiotics, allergic cross-sensitivity between Bettinger, Tawny L (coauthor) see Suehs,
Accreditation Council for Pharmacy Educa- penicillin and carbapenem antibiotics (A) Brandon T, 8
tion (ACPE), decides drug /d evice manu- 271 Bevacizumab, prolongs life in advanced colon
facturers cannot provide continuing educa- Anticoagulation (A), 69 cancer (TT), 289
tion (PF), 169; proposes new standards for Antacids, non-use increases risk for heart dis- Bisphosphonates, reduce fracture rates (TT),
PharmD degrees (PF), 169 ease (WN), 95; use by HIV patients (WN), 219
Acetaminophen, comparable to ibuprofen for 33 Bivalirudin, compared with eptifibatide after
ankle sprains (TT), 284 Antipsychotics, association with diabetes (A), PCI (TT), 29
Acute renal failure (MP), 188 8; association with neuroleptic malignant Black, Martin (coauthor) see Friedenberg,
Adherence, decreases with more pills (WN), syndrome (A), 262 Frank K, 207
95 Argatroban in Post-Cardiovascular Surgery Blood pressure, lowering provides benefits
Advertising, direct-to-consumereffects (PF), Patient with Heparin-Induced Thrombo- (TT), 29
cytopenia Requiring Hemodialysis and Book reviews, see New Publications
Albrecht, Linda S (author), book review, 367 Continuous Hemofiltration (A), 213 Books received, 48, 111, 179, 236, 306, 370
Allen, Richard R (coauthor) see Nair, Kavita Aripiprazole, treatment for schizoaffective Botulinum toxin type A, effective in overac-
V, 137 disorder (A), 150 tive bladder (TT), 287
Allergic Cross-Sensitivity Between Penicillin Aspirin, resistance increasing (WN), 160; safe- Bouwmeester, Carla J (author) Surveying
and Carbapenem Antibiotics (A), 271 ty of low vs high doses (TT), 354 Physicians’ Attitudes About Herbal Supple-
Allergy, cetirizine compared with fexofena- Asthma, hospitalizations due to poor drug ments, Resources, and Pharmacy Consulta-
dine (TT), 27; cross-sensitivity among (-lac- adherence (WN), 95; inhalers with spacers tions (A), 247
tams (A), 271; peanut allergy (A), 3; tips to as effective as nebulizers in children (WN), Bronchiolitis, treatment varies in children
reduce symptoms (WN), 159 291; suboptimal control in children (WN), (WN), 224
Allopurinol, pediatric formulation, 233 95; treatment with ciclesonide (TT), 155; Brown, Brenna (author) book review, 110
Alprazolam, pediatric formulation, 233 variability despite adherence to treatment Brownlee, Margaret “Peg” (author) book re-
Altman, Julie S (author) The Need for a More guidelines (WN), 33 view, 370
Stringent LDL-C Goal in Patients with Dia- Assisted living/home care, number of beds Brushwood, David B (coauthor), see Wilson,
betes (A), 325 available declines (WN), 357 Debbie L, 341
Alzheimer’s disease, African Americans Atherosclerosis, risk scores may predict coro- Budesonide, tolerability in asthma (TT), 93
treated with donepezil (TT), 219; treated nary heart disease (WN), 222 Burgess, Carl (coauthor) see Suisted, Philip,
with quetiapine (TT), 155 Atorvastatin: An Update of Recent Clinical 16
Akala, Folasade O (author) Understanding Trial Experience (A), 197 Busulfan, new delivery method (TT), 219
the Perceptions and Attitudes of Pharmacy Attention deficit hyperactivity disorder C-reactive protein, lowering reduces risk of
Students on Administering Adult Vaccines (ADHD), treated with methylphenidate myocardial infarction (WN), 96
(A), 254 (TT), 31 Calcium, fortified drinks are misleading
Amiloride, pediatric formulation, 302 Atypical Antipsychotics and Diabeies: Dis- (WN), 163; necessary before puberty in fe-
Amin, Kamal (author) Incidence of Acute Re- cussion and Monitoring Recommenda- males (WN), 99; reduces risk of colorectal
nal Failure Associated with Milrinone (A), tions (A), 8 cancer in women (WN), 99
21 Ault, Bettina H (coauthor) see Lau, Keith K, Calendar of Events, 44, 107, 175, 232, 301, 364
Amitryptyline, pediatric formulation, 302 213 Cancer, bevacizumab prolongs life in colorec-
Amlodipine, cardiovascular benefits in pa- Azathioprine, pediatric formulation, 45 tal cancer (TT), 289; book for children
tients with multiple risk factors (TT), 90; Azithromycin Extravasation in a Pediatric whose siblings have cancer (WN), 99; pa-
beneficial in patients with coronary artery Patient (A), 83 tients have unmet healthcare needs (WN),
disease (TT), 28; Baclofen, pediatric formulation, 45 35; survivors face long-term emotional and
Amsden, Guy W (coauthor) see Keller, Tracey Ballington, Don A (author) Preparing Sterile physical problems (WN), 163
A,3 Products Laboratory Supplies (A), 59 Candesartan, associated with pancreatitis (A),
Analyzing a Health-System’s Use of Unfrac- Barnes, Lisa C (author) book review, 367 79
tionated Heparin to Ensure Optimal Anti- Bastani, Bahar (coauthor) see Amin, Kamal, Carbamazepine, extended release capsule ef-
coagulation (A), 69 21 fective in bipolar disorder (TT), 31
Antibiotic-resistance, consumer awareness Belgeri, Myra T (author) Long-Acting An- Cardiac failure, practitioners’ compliance
growing (WN), 291; fluoroquinolone- and giotensin-Converting Enzyme Inhibitors in with guidelines (A), 16
WWW. JPHARMTECHNOL.COM Novemser/Decemser 2005 @ Vow.me21 @ J PHARMTECHNOL 377
Cardiac ischemia, differential treatments in De Soto, Joseph A (author) A Case Study: Etanercept, effective in psoriasis after dosage
blacks versus whites (WN), 159 Treatment of Refractory Schizoaffective Dis- reduction (TT), 286
Cardiovascular disease, associated with peri- order with Aripiprazole (A), 150 Etodolac, associated with few gastrointestinal
odontal bacteria (WN), 160; increased risk Depression, reduced by exercise (WN), 100 complications (WN), 33
of death within 2 years of losing a spouse Diabetes, and atypical antipsychotics (A), 8; Evans, Emily W (author) New Treatment for
(WN), 95; poor compliance with multidrug benefits of chromium (TT), 30, 284; cardio- Chronic Obstructive Pulmonary Disease:
regimens (WN), 95; poor use of aspirin in vascular benefits of tight glucose control Tiotropium Bromide (A), 144
at-risk population (WN), 95; women urged (TT), 285; chromium piccolinate reduces Exacta-Med, new oral dispenser available
to learn prevention (WN), 164 weight gain (TT), 285; exenatide for type 2 (WN), 162
Carvedilol, advantages in hypertension and diabetes mellitus (A), 191; group education Exenatide: A Novel Therapeutic Approach
diabetes (TT), 27 improves disease management (WN), 223: for Type 2 Diabetes Mellitus (A), 191
Cetirizine, efficacy superior to that of fexofe- hemoglobin Alc goals often not achieved Exercise, reduces depression (WN), 100
nadine (TT), 27 (WN), 223; increases risk of bacteremia Expanded Technician Roles vs Patient Safe-
Chang, Alan W (coauthor) see Friedenberg, (WN), 96; LDL-C goal needs to be more ty: Finding the Balance (FL), 38
Frank K, 207 stringent (A), 325; newly diagnosed chil- Exploring the Professional Expertise of Phar-
Chromium, role in diabetes (TT), 30 dren with type 2 commonly have psychi- macy Technicians (A), 341
Chromium picolinate, reduces diabetic atric illnesses (WN), 293; once-daily insulin Factors Associated with Ribavirin-Induced
weight gain (TT), 284 glargine improves glycemic control (TT), Anemia (A), 207
Chronic obstructive pulmonary disease, new 286; pioglitazone improves dyslipidemia Fatal Acute Pancreatitis in a Patient Chroni-
treatment (A), 144 (TT), 284; reduced risk with valsartan (TT), cally Treated with Candesartan (A), 79
Chronic pain syndromes, association with ac- 218; rimonabant improves HbA1c dyslipi- FDA Changes Affecting the Marketing of
tivity levels (WN), 100 demia (TT), 285; role of chromium (TT), 30; NSAIDs (FL), 225
Chua, Doson (coauthor) see Greanya, Erica D, role of exenatide (A), 191; rosiglitazone may Fexofenadine, efficacy compared with that of
271 reduce blood pressure (TT), 286; tight glu- cetirizine (TT), 27
Ciclesonide, improves asthma (TT), 155 cose control lowers risk of heart disease Fluticasone, less preferred than mometasone
Cisneros, Bob (author) book review, 369 (TT), 285; updated guidelines (WN), 96 (TT), 353
Clindamycin, pediatric formulation, 109 Donepezil, for mild to moderate Alzheimer’s Fluoroginolone- and Methicillin-Resistant
Clinical trials, pediatric participation (WN), disease in African Americans (TT), 219 Staphylococcus aureus: Insights from the
36; perceived safe by Americans (PF), 103 Drug adherence, compromised by multiple- Antimicrobial Resistance Management
Clonazepam, pediatric formulation, 109 drug regimens (WN), 95; improved with Program (A), 123
Clonidine, pediatric formulation, 177 Concerta compared with other Folic acid, may prevent hypertension (WN),
Clopidogrel, increased effectiveness prior to methylphenidates (TT), 289 165; increased use needed (WN), 359
angioplasty (TT), 354 Drug abuse, abuse of attention-deficit disor- Fondaparinux, comparable to enoxaparin
Cohen, Victor (coauthor) see Jellinek, Saman- der stimulants among college students to (TT), 353
tha P, 69 stay awake (WN), 97; an epidemic with Friedenberg, Frank K (author) Factors Asso-
Community-Focused Pharmacy, offers medi- controlled prescriptions (WN), 293; has de- ciated with Ribavirin-Induced Anemia (A),
cation therapy management services (PF), 41 clined overall among teens (WN), 96; grow- 207
Compounding, advances in quality (PF), 228 ing in patients with eating disorders (WN) From the Literature, 38, 101, 167, 225, 296, 361
Compounding Formulations, allopurinol 294; prescription drugs, detection (WN), From the States, 42, 105, 171, 230, 299
20 mg/mL oral suspension, 233; alprazolam 356; Remoxy formulation of oxycodone less
1 mg/mL oral suspension, 233; amiloride likely to be abused than OxyContin (TT), 89
1 mg/mL oral suspension, 302; amitrypty- Drug delivery, techniques to enhance efficacy G-I
line 1 mg/mL oral liquid, 302; azathioprine (WN), 161
50 mg/mL oral suspension, 45; baclofen Drug Name Confusion: Preventing Medica- Gefitinib, roles in multiple tumor types (TT),
10 mg/mL oral suspension, 45; busulfan tion Errors (FL), 296 31
2 mg/mL oral suspension, 365; cefazolin Drug safety, child-resistant caps not always Generic drugs, “authorized generics” success-
33 mg/mL ophthalmic drops, 365 ; clinda- effective (WN), 163; Partnership for Safe ful marketing strategy (WN) 360; believed
mycin 15 mg/mL injection, 109; clonaze- Medicines (WN), 224 to be safe and effective by Americans (WN),
pam 0.1 mg/mL oral suspension, 109; cloni- Duloxetine, improves cognition in elderly 98; programs halt prescription drug spend-
dine 0.1 mg/mL oral suspension, 177; cyclo- (TT), 157; treatment of stress incontinence ing (WN), 297; save money (WN), 98
phosphamide 2m g/mL elixir (oral), 177 (A), 337 Gill, ChristopherJ (author) Fatal Acute Pan-
Conjunctivitis sicca, associated with Eckel, Stephen F (author), book review, 179; creatitis in a Patient Chronically Treated
menopause (WN), 99 235 with Candesartan (A), 79
Controlling Pertussis Outbreaks (FL), 225 “Educational Pearls”: 2005 Pharmacy Techni- Glatiramer, effective in relapsing-remitting
Correction, azithromycin extravasation in a cian Educators Council Annual Meeting multiple sclerosis (TT), 288
pediatric patient, 180 Report (A), 281 Gloria, Rodel R (coauthor) see Ward, Michael
Corticosteroids, via nebulizer associated with Egg, part of heart-healthy diet (WN), 160 C, 276
better outcomes in children with asthma End-of-life-care, most prefer final days at Goldman, William M (coauthor) see Jellinek,
(TT), 155 home (WN), 36 Samantha P, 69
Cyclooxygenase-2 inhibitors, not as safe as Encephalopathy and Hyp Gollamudi, Satya P (coauthor) see Frieden-
combination therapy (TT), 220; use has de- sociated with Valproic Acid (A), 348 berg, Frank K, 207
clined (WN), 159 Enfuvirtide, combined with protease in- Gong, William C (author) book review, 47
Cyclophosphamide, pediatric formulation, hibitors improves viral suppression (TT), Greanya, Erica D (author) Allergic Cross-Sen-
177 156 sitivity Between Penicillin and Carbapenem
Cyclosporine, inhalation solution improves Enoxaparin, comparable to fondaparinux Antibiotics (A), 271
survival in lung transplant recipients (TT), (TT), 353 Greenwood, Robert B (author) book review,
221 “Ephedra-free” supplements, health risks 234
(TT), 355 Guatam, Manjushree (coauthor) see Frieden-
Epilepsy, can occur at any age (FL), 361 berg, Frank K, 207
D-F Epstein, Benjamin J (coauthor) see Gums, Gums, John G (author) Fluoroquinolone- and
John G, 123 Methicillin-Resistant Staphylococcus aureus:
Darifenacin, lack of cognitive impairment in Eptifibatide, differences compared to bi- Insights from the Antimicrobial Resistance
elderly (TT), 158 valirudin (TT), 29; superior to clopidogrel Management Program (A), 123
Davis, Steven (coauthor) see Osborne, Kristie alone for platelet inhibition (TT), 29 Gupta, Rahul (coauthor) see Wargo, Kurt A,
L, 337 Escue, EricJ ( coauthor) see Lau, Keith K, 213 262
DeSantis, Evelyn R Hermes (author) book re- Eszopiclone, improves insomnia associated Hall, Catherine S (coauthor) see Suehs, Bran-
view, 178 with depression (TT), 93 don T, 8
378 J PHarmTecHNo. @ Votume21 Novemser/Decemser 2005
INDEX
Harrell, T Kristopher (author) Overview of J/A, ife-S/O, ifc-N /D; subscription order Mendys, Philip M (author) Atorvastatin: An
Pharmacologic Treatment of Obesity: Past form, 25, 87, 154, 217, 283, 351 Update of Recent Clinical Trial Experience
Experiences, Present Options, and Future Katz, Michael J (author) Acute Renal Failure (A), 197
Directions (A), 319 (MP), 188; Atrial Fibrillation (MP), 244; Hy- Menopause, associated with chronic dry eyes
Health care, consumers worry about safety percholesterolemia (MP), 316; Pain (MP), (WN), 99; hormone therapy supported by
(PF), 40; racial disparity in newer heart 120; Pancreatitis (MP), 56 NIH (WN), 166; noninvasive test available
treatments (WN), 159; reform needed Kazi, Aneela (coauthor) see De Soto, Joseph (WN), 165;
(WN), 97 A, 150 Merck Withdraws Vioxx: FDA Issues Public
Health-system, drug spending increasing Keller, Tracey A (author) Peanut Allergy Health Advisory (FL), 39
moderately (PF), 103 Treatment: Past, Present, and Future (A), 3 Metabolic syndrome, increases risk of chronic
Heartburn, associated with HIV therapy Keresztes, Jan M (author) book review, 303 kidney disease (TT), 287
(WN), 34 Kerr, Jessica L (coauthor) see Altman, Julie S, Methylphenidate, adherence to Concerta ex-
Heart disease, benefits of aspirin (WN), 95; 325 ceeds that of other formulations (TT), 289;
women urged to learn prevention (WN), 164 Kidney disease, chronic, lack of recommend- efficacy of higher doses in ADHD (TT), 31
Heart failure, role of ACE inhibitor dosing ed care (WN), 359 Mifepristone, approval questioned (WN), 37;
schedules (A), 203; study completed in Kimberlin, Carole L (coauthor) see Wilson, proposed mechanism to explain fatal infec-
African Americans (TT), 29 Debbie L, 341 tions (WN), 295
Hepatitis B, treated with peginterferon alfa-2b King, Deborah S (coauthor) see Harrell, T Migraine, economic and psychosocial impacts
(TT), 89 Kristopher, 319 (A), 129
Herbal supplements, physicians’ attitudes King, Devin A (coauthor) see Ward, Michael Milk thistle, ineffective at reducing liver dis-
(A), 247 C, 276 ease mortality (WN), 222
Hey, Diana M (author) Azithromycin Ex- Koontz, Susannah E (coauthor) Hey, Diana Milrinone, association with renal failure (A),
travasation in a Pediatric Patient (A), 83 M, 83 21
HIV, prevention hindered among African Kourlas, Helen (coauthor) see Thapa, Srad- Mometasone, preferred over fluticasone (TT),
Americans because of misconceptions dha, 330 353
(WN), 98; protease inhibitors associated Lashley, Eustace L (coauthor) see Jellinek, Muhammad, Wilson AB (coauthor) see De
with arrhythmias (WN), 162; treatment Samantha P, 69 Soto, Joseph A, 150
with enfuvirtide plus protease inhibitors Lau, Keith K (author) Argatroban in Post- Myeloma, treated with thalidomide (TT), 91
improves viral suppression (TT), 156; viru- Cardiovascular Surgery Patient with Hep- Myocardial infarction, treatment gap lessen-
lence attenuating (WN), 358 arin-Induced Thrombocytopenia Requiring ing for women (TT), 158
Hume, Anne L (author) book review, 303; use Hemodialysis and Continuous Hemofiltra- Nair, Kavita V (author) Impact of Increased
of antacids and heartburn drugs in patient tion (A), 213 Copayments on the Discontinuation /
population (WN), 33 Laxatives, misconceptions about use (WN), 97 Switching Rates of Nonformulary Medica-
Hypercholesterolemia, treatment during Levin, Gary M (coauthor) see Weitzel, Kristin tions (A), 137
pregnancy (A), 258; (MP), 316 Wiisanen, 129 National Council for Prescription Drug Pro-
Hyperglycemia, slows mental functions Lewis, Sonya J (coauthor) see Nair, Kavita V, grams (NCPDP), announces educational
(WN), 96 137 summits (PF), 229; supports idea of profes-
Hypertension, prevention with folic acid Likourezos, Antonios (coauthor) see Jellinek, sional service billing codes (PF), 298
(WN), 165 Samantha P, 69 National Pharmacists Association, joint Phar-
Ibuprofen, comparable to acetaminophen for Link, Mirranda (coauthor) see Ward, Michael macists Council with United Steelworkers
ankle sprains (TT), 284 C, 276 (PF), 363
Impact of Increased Copayments on the Dis- Lloyd, Stanley J (author) “Educational The Need for a More Stringent LDL-C Goal
continuation/Switching Rates of Nonfor- Pearls”: 2005 Pharmacy Technician Educa- in Patients with Diabetes (A), 325
mulary Medications (A), 137 tors Council Annual Meeting Report (A), Neuroleptic Malignant Syndrome: No
Incidence of Acute Renal Failure Associated 281 Longer Exclusively a “Neuroleptic” Phe-
with Milrinone (A), 21 Long-Acting Angiotensin-Converting En- nomenon (A), 262
Indiplon, treats insomnia (TT), 288 zyme Inhibitors in Congestive Heart Fail- New Publications, Building a Medical Vocabu-
Infant formula, docosahexaenoic acid and ure: Does Multiple-Daily Dosing Provide lary with Spanish Translations, 6th Edition, 370;
arachidonic acid additives aid infant devel- Additional Benefit Over Once-Daily Dos- Building a Successful Collaborative Pharmacy
opment (TT), 220 ing? (A), 203 Practice: Guidelines and Tools, 110; Certification
Infectious disease, hand-washing vs antiviral Review for Pharmacy Technicians, 7th Edition,
tissues (WN), 358; Web site provides latest 303; Compounding Sterile Preparations, 2nd
HI/ AVIDS , tuberculosis, and malaria infor- M-N Edition, 234; Manual for Pharmacy Technicians,
mation (WN), 223 3rd Edition, 304; Handbook on Injectable
Infliximab, dosing stable over 2 years (TT), Management of Benign Prostatic Hyperpla- Drugs, 13th Edition, 367; Pharmaceutical Cal-
30; effective in rheumatoid arthritis remis- sia (A), 330 culations, 4th Edition, 367; Pharmacy Techni-
sion (TT), 32; reduces pain associated with Management of Cardiac Failure-Do Practi- cian Certification and Practice Exam, 2nd Edi-
Crohn’s disease (TT), 30; safety data pre- tioners Follow Guidelines? (A), 16 tion, 305; Preparing a Health Care Workforce for
sented (TT), 32 McCord, Amie D (author) Exenatide: A Nov- the 21st Century: the Challenge of Chronic Con-
Insulin glargine, improves glycemic control el Therapeutic Approach for Type 2 Dia- ditions, 303; Preparing to Meet Joint Commis-
(TT), 286 betes Mellitus (A), 191 sion Patient Safety Goals: A Supplement to
International Academy of Compounding Meckley, Marintha Rae (author) book review, Preparing the Pharmacy for a Joint Commission
Pharmacy, files Amicus brief (PF), 41 110 Survey, 5th Edition, 179; The Baptist Health
Medical Problems: Brief Reviews, 56, 120, Care Journey to Excellence: Creating a Culture
j-t 188, 244, 316 that WOWs!, 235; The Breast Cancer Care Book:
Medicare, recent changes (A), 63 A Survival Guide for Patients and Loved Ones,
Medication errors, based on drug name con- 111; The Children’s Hospital of Philadelphia
Jellinek, Samantha P (author) Analyzing a fusion (FL), 296 Guide to Asthma: How to Help Your Child Live a
Health-System’s Use of Unfractionated Medication safety, improving (WN), 292; im- Healthier Life, 46; The Future of Primary Care,
Heparin to Ensure Optimal Anticoagula- proving in patients with kidney disease 47; The Handbook of Clinically Tested Herbal
tion (A), 69 (WN), 292 Remedies, Volumes 1 and 2, 178; The Pharmacy
Jennings, Anne E (coauthor) see Gill, Christo- Medication management services (A), 63 Technician: A Comprehensive Approach, 369
pher J, 79 Medication therapy management, billing New Treatment for Chronic Obstructive Pul-
Jones, Deborah P (ccauthor) see Lau, Keith K, codes approved (PF), 298; components monary Disease: Tiotropium Bromide (A),
213 identified (PF), 228 144
journal of Pharmacy Technology, author Medroxyprogesterone, associated with Newton, Jeffrey B (coauthor) see Gill,
guidelines, ifc-J/F, ife-M/A, ife-M/J, ifc- thrombosis (A), 276 Christopher J, 79
WWW. JPHARMTECHNOL.COM Novemser/Decemser 2005 @ Vowume 21 m@ J PHARMTECHNOL 379
Normotensive patients, benefit from blood cists (FS), 42; Illinois pharmacists assess Rivera, Alejandro (coauthor) see De Soto,
pressure lowering (TT), 29 technician training program (FS), 171; Joseph A, 150
Michigan Society of Pharmacy Technicians Rofecoxib, withdrawn voluntarily (FL), 39
O-R (FS), 105; Mississippi Academy of Pharma- Ropinirole, effective in restless legs syndrome
cy Technicians (FS), 43; new program for (TT), 90
clinical technicians (FS), 230; op- Rosacea, effect on self-esteem (WN), 356; trig-
Obesity, pharmacologic treatment (A), 319 portunities for y technicians (FS), gered by exercise (WN), 161
Olanzapine, reduces violent behavior in 299; organizations meet (PF), 40; participa- Rosiglitazone, benefits blood pressure (TT),
schizophrenia (TT), 92 tion in population management program 286
Oral contraceptives, low doses increase risk for (FS), 299; preparing sterile products labora- Ross, Leigh Ann (coauthor) see Harrell, T
myocardial infarction and stroke (TT), 290 tory supplies (A), 59; professional expertise Kristopher, 319
Order scanning systems, increase pharmacy (A), 341; technician involvement in Penn- Rosuvastatin, effective in African Americans
productivity (PF), 227 sylvania (FS), 173; technicians participating (TT), 28
Ormiston, Thomas M (coauthor) see Yee, Jen- in Pharmacy Day (FS), 231; ician’s role
nie L, 348 in California (FS), 171; Washington State
Osborne, Kristie L (author) Duloxetine in the roundtable survey (FS), 173 S-Z
Treatment of Stress Urinary Incontinence Photodynamic antimicrobial therapy, effec-
(A), 337 tive against methicillin-resistant Staphylo- Safeguards for Children Taking Antidepres-
Osteoporosis, bisphosphonate treatment re- coccus aureus (WN), 358 sants Strengthened (FL), 101
duces fracture risk (TT), 219; Surgeon Gen- Pioglitazone, improves diabetic dyslipidemia Saquinavir, fortovase formulation to be dis-
eral’s report (WN), 35; therapies used by (TT), 284; reverses carotid wall thickening continued (WN), 223
women due to fear of losing independence (TT), 27 Schizophrenia, improved medication adher-
(WN), 165 Pneumonia, new vaccine reduces antibiotic ence with atypical agents (TT), 221; long-
Overactive bladder, treatment with (-blockers resistance (WN), 162 acting risperidone may slow relapse (TT),
and tolterodine (TT), 32; treatment with bo- Ponte, Charles D (author) book review, 46 290; symptoms commonly overlooked
tulinum toxin type A (TT), 287 Powers Mary F (author) Recently Approved (WN), 164
Over-the-counter (OTC) medications, abused Medicare Provisions for Prescription Drugs Schmutz, Joan K (coauthor) see Friedenberg,
to control weight (WN), 294; Rx-to-OTC and Medication Management Services (A), Frank K, 207
switch advocated by consumers according 63; (coauthor) see Akala, Folasade O, 254 Schwartz, David E (coauthor) see Gill,
to survey (WN), 34; provide financial and Pramipexole, effective in restless legs syn- Christopher J, 79
health benefits (WN), 34 drome (TT), 156 Skole, Kevin S (coauthor) see Friedenberg,
Overview of Pharmacologic Treatment of Preparing Sterile Products Laboratory Sup- Frank K, 207
Obesity: Past Experiences, Present Op- plies (A), 59 Seneviratne, Sujith (coauthor) see Suisted,
tions, and Future Directions (A), 319 Prescribing errors, pharmacists can reduce in- Philip, 16
Oxycodone, Remoxy formulation less abus- cidence (PF), 363 ShrinkSafe, paralytic identification bands
able than OxyContin (TT), 89 Prostatic hyperplasia, benign, management (WN), 34
Packaging, amber oral dispensers available (A), 330 Simpson, Ross J Jr (coauthor) see Mendys,
(WN), 162; child-resistant caps, not always Protease inhibitors, associated with cardiac Philip M, 197
effective (WN), 163 arrhythmias (WN), 162 Sleep apnea, deaths most common in young
Pain, review (MP), 120; pain-free needles Proton-pump inhibitors, control acid during men (WN), 164
(WN), 357 NSAID therapy (TT), 219; use with NSAIDs Spanish, pamphlets available for medicating
Palliative care, people prefer to live final days is safer than COX-2 inhibitors (TT), 220 children (WN), 224
at home (WN), 36 Psychiatric illnesses, common in children Staphylococcus aureus, management of drug-
Pancreatitis (MP), 56 with newly diagnosed diabetes (WN), 293 resistant strains (A), 123
Parkinson’s disease, treatment with rasagiline Psyllium, efficacy for lowering LDL-C (TT), Statins, halt progression of atherosclerosis
(TT), 157 28 (TT), 218; in the elderly (TT), 218
Partnership for Safe Medicines, protects Quetiapine, effective for Alzheimer’s disease Stem cell research, funding opposed by ma-
against counterfeit drugs (WN), 224 (TT), 155; effective for bipolar disorder (TT), jority of Americans (WN), 222
Patient counseling, education for physicians 289 SterilSHIELD Barrier Isolator, 2 models
necessary for “telephone medicine” (WN), Radiofrequency Identification Technology: available (WN), 293
360 Protecting the Drug Supply (FL), 167 Streptococcus pneumoniae, drug-resistant
Patients, prefer drugs that have been market- Ramelteon, effective in chronic insomnia (TT), strains decline with introduction of child-
ed for more than 10 years (PF), 227; Spanish 288 hood vaccine (WN), 162
pediatric medication pamphlet available Rasagiline, improves Parkinson's disease Storgion, Stephanie A (coauthor) see Lau,
(WN), 224; uncertain about Web-based symptoms (TT), 157 Keith K, 213
health information (WN), 291; uncomfort- Raval, Kalindi D (coauthor) see Zaiken, Suehs, Brandon T (author) Atypical Antipsy-
able confronting medical personnel (WN), Kathy, 258 chotics and Diabetes: Discussion and Moni-
162 Recently Approved Medicare Provisions for toring Recommendations (A), 8
Peanut Allergy Treatment: Past, Present, and Prescription Drugs and Medication Man- Suisted, Philip (author) Management of Car-
Future (A), 3 agement Services (A), 63 diac Failure-Do Practitioners Follow Guide-
Peginterferon alfa-2b, monotherapy effective Recombinant activated factor VIIa, effective lines? (A), 16
in hepatitis B (TT), 89 in stroke (TT), 156 Surfactant, role in treating premature infants
Penicillin, carbapenem cross-sensitivity (A), Restless legs syndrome, treated with (TT), 31
271 pramipexole (TT), 156; treated with ropinin- Surgeon General, reports concern over bone
Perindopril, beneficial in elderly post-MI pa- role (TT), 90 health (WN), 35
tients (TT), 354; cardiovascular benefits Rheumatoid arthritis, remission maintained Surveying Physicians’ Attitudes About
(TT), 354 with infliximab (TT), 31 Herbal Supplements, Resources, and
Periodontal bacteremia, association with car- Ribavirin, associated with anemia (A), 207 Pharmacy Consultations (A), 247
diovascular disease (WN), 160 Rimonabant, helps with weight loss (WN), Taylor, James R (coauthor) see Ward, Michael
PharmaCE, order form, 50, 115, 183, 240, 308, 35; improves HbA1c and cardiometabolic C, 276
372; questions, 51, 113, 181, 237, 237, 309, 373 risk factors (TT), 285 Test Your Knowledge, answers, 53, 116, 184,
Pharmacogenomics, impact on drug develop- Rios, Joanne M (author) book review, 304, 305 241, 312, 376; questions, 2, 58, 122, 190, 246,
ment (PF), 169 Risperidone, long-acting formulation may re- 318
Pharmacy Focus, 40, 103, 169, 227, 297, 363 duce schizophrenia relapses (TT), 290; toler- Tinidazole, effective in trichomoniasis (TT),
technicians, Arizona technician ability compared with ziprasidone (TT), 93 357
summit (FS), 105; expanded roles (FL), 38; Rivastigmine, for dementia associated with Thalidomide, for treatment of myeloma (TT),
Illinois Council of Health-System pharma- Parkinson's disease (TT), 91 91
380 J)P HARM TECHNOL @ VoiumMe21 Novemser/Decemser 2005
Thapa, Sraddha (author) Management of Be- Web-based health information, credibility
nign Prostatic Hyperplasia (A), 330 difficult for older Americans to discern Index Abbreviations
Thrombosis Secondary to Medroxyproges- (WN), 291
terone in Patient at Risk forT hromboem- Web site, warns of risks of drug importation
bolism (A), 276 (PF), 297 Article
The Economic and Psychosocial Impact of What's New, 33, 95, 159, 222, 291, 356
Migraine Before and After Diagnosis and Weitzel, Kristin Wiisanen (author) The Eco-
Treatment (A), 129 nomic and Psychosocial Impact of Migraine
Therapeutic Trends, 27, 89, 155, 218, 284, 353 Before and After Diagnosis and Treatment
Thomas, Rebecca M (coauthor) see Frieden- (A), 129; (coauthor) see Ward, Michael C,
berg, Frank K, 207 276
Thrower, Margaret R (coauthor) see Altman, Wilson, Debbie L (author) Exploring the Pro-
Julie S, 325 fessional Expertise of Pharmacy Technicians
Tinidazole, effective for trichomoniasis (TT), (A), 341
30 Wong, David (coauthor) see Yee, Jennie L, 348
Tiotropium bromide, for chronic obstructive Yee, Jennie L (author) Encephalopathy and
pulmonary disease (A), 144 Hyperammonemia Associated with Val-
Tolterodine, combination with (-blockers is ef- proic Acid (A), 348
fective for treating overactive bladder in Zaiken, Kathy (author) Treatment of Hyperc-
males (TT), 32; first-line choice for overac- holesterolemia in Pregnancy: Risks Versus
tive bladder treatment (TT), 94 Benefits (A), 258
Treatment of Hypercholesterolemia in Preg- Ziprasidone, effective in psychiatric emergen-
nancy: Risks Versus Benefits (A), 258 cies (TT), 220; equally effective and better
Trichomoniasis, treated with tinidazole (TT), tolerated than risperidone (TT), 93
30 Zolmitriptan, nasal spray is safe in long-term
Understanding the Perceptions and Atti- migraine treatment (TT), 91; provides total
tudes of Pharmacy Students on Adminis- relief from migraine symptoms (TT), 92
Statement of ownership, management, and monthly cir-
tering Adult Vaccines (A), 254
culation (6 issues, $160.00 annually) of the journal of
Unfractionated heparin, for optimal anticoag-
ulation (A), 69 Advertisers PHharavremya cyW hiTtenchenyo lBoogoyk,s pCubolmipcaantiyo.n Pnou.b li8s7h5e5r-,1 22e5di.t orO,w naenrd,
Vaccines, attitudes of pharmacy students managing editor: Harvey AK Whitney Jr. Headquarters
about administration (A), 254; new vaccine American Association of Pharmacy Techni- of publisher, owner, and publication: 8044 Montgomery
reduces antibiotic resistance (WN), 162 cians (AAPT), 94, 166, 206, 243 Road, PO Box 42696, Cincinnati, OH 45242. Known
Valproic acid, encephalopathy and hyperam- Harvey Whitney Books Company, Certifica- bondholders, mortgages, and other security holders:
monemia (A), 348 tion Review for Pharmacy Technicians, Seventh none. Average no. of copies of each issue from October
Valsartan, lowers risk of diabetes (TT), 218 Edition, ibc-M/A, ibc-M/J, ibc-J/ A, ibe- 2004 to October 2005 and no. of copies of November /De-
cember 2003 to September /October 2004 issue: A. total
Valuck, Robert J (coauthor) see Nair, Kavita S/O, 352; Medical Abbreviations, 12th Edi- no. copies printed (net press run) 600, 600; B. paid
V, 137 tion, 253; Pediatric Drug Formulations, Fifth and/ o r requested circulation (1) paid or requested mail
Ward, Michael C (author) Thrombosis Sec- Edition, Revised, ibc-J /F, 104, 168, 366; Prin- subscriptions 371, 370; C. total paid and /or requested
ondary to Medroxyprogesterone in Patient ciples of Pharmacoeconomics, Third Edition, circulation 434, 446; D. free distribution by mail 58, 58; F.
at Risk for Thromboembolism (A), 276 26, 88, 176, 382; Therapeutics in the Elderly, total iree distribution 58, 58; G. total distribution 492, 504;
Wargo, Kurt A (author) Neuroleptic Malig- Third Edition, 108, ibe-N/D H. copies not distributed 108, 96; I. Total 600, 600. No. of
nant Syndrome: No Longer Exclusively a Pharmacy Technician Educators Council issues published annually: 6. Date of filing 1 October
“Neuroleptic” Phenomenon (A), 262 (PTEC), 86, 128, 187 2005. Signed: Harvey AK Whitney Jr, publisher.
Novemser/Decemser 2005 mw Voiume21 @ J PHARMTECHNOL 381